// App-Quantinova.ai

4028 : Lenalidomide with Low or Intermediate Dose Dexamethasone in Patients with Relapsed or Refractory Myeloma

Researchers

Presenter

  • Maria Roussou

Principal Investigators

  • Maria Gavriatopoulou

  • Magdalini Migkou

  • Maria Gkotzamanidou

  • Evangelos Eleutherakis-Papaiakovou

  • Dimitrios Christoulas

  • Evangelos Terpos

  • Efstathios Kastritis

Medical Centers

  • Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Arrhythmia

  • Pulmonary embolism

  • Renal insufficiency

  • Neutropenia

  • Venous thrombosis

Biomarkers

  • Creatinine

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • Thalidomide

  • Bortezomib

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved